GNPX

Genprex Inc

NASDAQ: GNPX · HEALTHCARE · BIOTECHNOLOGY

$2.24

+9.80% today

Updated 2026-10-30

Market cap

$1.62M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-9.05

Dividend yield

—

52W range

$2 – $218

Volume

0.2M

Market cap

$1.62M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-9.05

Dividend yield

—

52W range

$2 – $218

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.3

Quality

C+

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

-25.7

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →251 stocks currently score above 75

Price targets

Analyst target

$7.50

+234.82%

12-Month target

$4.25

+89.73%

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 3/9 — weak financial health

- Altman Z -25.70 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-5.14M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-23.74M	$-30.86M	$-21.11M	$-16.23M	$-4.45M
EPS	—	—	—	—	$-9.05
Free cash flow	$-17.78M	$-24.81M	$-17.15M	$-15.31M	$-5.14M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
GNPX	$1.62M	26	4.3	3.0	5.0	5.3	—	Avoid
LLY	$1.26T	74	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$657.68B	54	4.7	8.5	2.7	5.5	-89.35%	Buy
ABBV	$521.11B	77	6.7	9.0	4.0	5.0	-88.02%	Strong Buy
MRK	$368.89B	44	3.3	6.5	2.0	5.0	-76.61%	Hold
UNH	$365.29B	62	6.7	6.0	4.7	5.5	-24.78%	Buy

Smart narrative

Genprex Inc trades at $2.24. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -25.70, it sits in the distress.

Frequently asked questions

What is Genprex Inc's stock price?

Genprex Inc (GNPX) trades at $2.24.

Is Genprex Inc overvalued?

Genprex Inc carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Genprex Inc (GNPX)?

The 12-month analyst consensus target is $7.50, about 234.8% above the current $2.24. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Genprex Inc's Altman Z-Score is -25.70, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-160.80%

Beta-0.98

50D MA$3.24

200D MA$21.91

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

GNPX vs LLY →GNPX vs JNJ →GNPX vs ABBV →Stock screener →